Filing Details
- Accession Number:
- 0000874015-13-000067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-26 19:45:26
- Reporting Period:
- 2013-06-24
- Filing Date:
- 2013-06-26
- Accepted Time:
- 2013-06-26 19:45:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1442730 | S Richard Geary | C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Svp, Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-06-24 | 13,730 | $15.38 | 17,984 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-24 | 13,730 | $25.22 | 4,254 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-06-24 | 6,270 | $15.38 | 10,524 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-24 | 6,270 | $25.16 | 4,254 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-06-24 | 10,000 | $15.75 | 14,254 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-24 | 10,000 | $25.16 | 4,254 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-06-25 | 1,049 | $6.81 | 5,303 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-25 | 1,049 | $27.56 | 4,254 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-06-25 | 4,000 | $15.38 | 8,254 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-25 | 4,000 | $28.32 | 4,254 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-06-25 | 1,565 | $14.47 | 5,819 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-25 | 1,565 | $28.32 | 4,254 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-06-25 | 10,435 | $14.47 | 14,689 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-25 | 10,435 | $27.87 | 4,254 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-06-24 | 20,000 | $0.00 | 20,000 | $15.38 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-06-24 | 10,000 | $0.00 | 10,000 | $15.75 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-06-25 | 1,049 | $0.00 | 1,049 | $6.81 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-06-25 | 4,000 | $0.00 | 4,000 | $15.38 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-06-25 | 12,000 | $0.00 | 12,000 | $14.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,000 | 2012-01-02 | 2015-01-01 | No | 4 | M | Direct |
| 0 | 2012-01-01 | 2014-12-31 | No | 4 | M | Direct |
| 0 | 2008-01-02 | 2014-01-01 | No | 4 | M | Direct |
| 0 | 2012-01-02 | 2015-01-01 | No | 4 | M | Direct |
| 16,960 | 2013-01-02 | 2016-01-01 | No | 4 | M | Direct |
Footnotes
- Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 10/14/10.
- Acquired as a result of exercising a stock option that was scheduled to expire on 1/1/14. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 2/3/09.
Billionaire Hedge Funds
